Recent studies have suggested that detemir displays an increased IGF-1 like activity and mitogenic potency compared with human insulin: Weinstein et al. [28] examined a number of cancer cells and concluded that detemir along with several other insulin analogues exhibited in vitro proliferative and anti-apoptotic activities compared to human insulin. This evidence concerns the gene INS and cancer.